Source - RNS
RNS Number : 9706K
Rex Bionics PLC
27 September 2016
 

Rex Bionics plc

("Rex Bionics" or the "Company")

 

Directors Interests

 

27 September 2016 Rex Bionics plc (AIM: RXB),  the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, announces that pursuant to the existing Deferred Bonus Share Plan (under which employees are issued options to subscribe for cash at par  for Ordinary Shares in respect of  the bonus to which they were  otherwise entitled)  the Company has  made awards, for the financial year ended 31 March 2016, in respect of an aggregate of 791,279 Ordinary Shares of 10p each in the Company ("Ordinary Shares") (representing 3.1% of the current issued Ordinary Shares) to certain employees in the Company including the Chief Executive Officer, the Chief Financial Officer and the Chief Technology Officer.

The Awards to those Directors are as follows:

Name

Deferred Bonus Award Shares

 

Crispin Simon
Chief Executive Officer

140,000

 

Peter Worrall
Chief Financial Officer

93,333

Richard Little
Chief Technology Officer

134,070

 

 

For further information please contact:

 

Rex Bionics Plc

Peter Worrall, Chief Financial Officer

+44 (0) 142 864 5416

 

Stifel Securities Limited (NOMAD and Broker)

Jonathan Senior, Stewart Wallace, Ben Maddison

+44 (0) 20 7710 7600

 

Consilium Strategic Communications

Lindsey Neville

[email protected]

+44 (0) 203 709 5700

 



Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name:  CRISPIN SIMON

 

2.

 

Reason for the notification

(a)

Position/status:  CHIEF EXECUTIVE

(b)

Initial notification/Amendment: INITIAL

 

3.

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name:  REX BIONICS plc

(b)

LEI: NA

 

4.

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial instrument, type of instrument: Rex Bionics Option over Ordinary Shares of 10p each

Identification code:  ISIN: GB00BLRLQM66

(b)

Nature of the transaction: Issue of awards under Deferred Bonus Share Plan

(c)

Price(s) and volume(s)

Price(s):              10p per Ordinary Share

Volume(s):          140,000

(d)

Aggregated information

·  Aggregated volume:    140,000 Ordinary Shares awarded

·  Price:                         Exercise price: 10p per Ordinary Share

 

(e)

Date of the transaction:  27 September 2016

(f)

Place of the transaction:  London Stock Exchange - AIM

 



 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name:  PETER WORRALL

 

2.

 

Reason for the notification

(a)

Position/status:  CHIEF FINANCIAL OFFICER

(b)

Initial notification/Amendment: INITIAL

 

3.

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name:  REX BIONICS plc

(b)

LEI: NA

 

4.

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial instrument, type of instrument: Rex Bionics Option over Ordinary Shares of 10p each

Identification code:  ISIN: GB00BLRLQM66

(b)

Nature of the transaction: Issue of awards under Deferred Bonus Share Plan

(c)

Price(s) and volume(s)

Price(s):              10p per Ordinary Share

Volume(s):          93,333

(d)

Aggregated information

·  Aggregated volume:    93,333 Ordinary Shares awarded

·  Price:                         Exercise price: 10p per Ordinary Share

 

(e)

Date of the transaction:  27 September 2016

(f)

Place of the transaction:  London Stock Exchange - AIM

 



 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name:  RICHARD LITTLE

 

2.

 

Reason for the notification

(a)

Position/status:  CHIEF TECHNOLOGY OFFICER

(b)

Initial notification/Amendment: INITIAL

 

3.

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name:  REX BIONICS plc

(b)

LEI:  NA

 

4.

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial instrument, type of instrument: Rex Bionics Option over Ordinary Shares of 10p each

Identification code:  ISIN: GB00BLRLQM66

(b)

Nature of the transaction: Issue of awards under Deferred Bonus Share Plan

(c)

Price(s) and volume(s)

Price(s):              10p per Ordinary Share

Volume(s):          134,070

(d)

Aggregated information

·  Aggregated volume:    134,070 Ordinary Shares awarded

·  Price:                         Exercise price: 10p per Ordinary Share

 

(e)

Date of the transaction:  27 September 2016

(f)

Place of the transaction:  London Stock Exchange - AIM

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFELATIDFIR

Related Charts

Rex Bionics (RXB)

-0.50p (-2.44%)
delayed 18:15PM